The Treatment of Elderly Patients With Lymphoma
Andre Goy, MD, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the treatment of elderly patients with lymphoma.
Clinical Pearls
Andre Goy, MD, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the treatment of elderly patients with lymphoma.
- Data from the GELA trial were impressive: Benefit was seen regardless of age with the R-CHOP combination
- Elderly patients typically have more aggressive and higher risk disease
- The standard of care is R-CHOP-21, though patients in good condition with high-risk disease can tolerate R-EPOCH
- Frail patients should be treated with mini-CHOP
- The incidence of large cell lymphoma in the elderly has increased 500% in the last 10 years, creating a need for better therapeutic options
FDA Greenlights Treosulfan/Fludarabine Combo for AlloHSCT in AML and MDS
January 24th 2025The combination of treosulfan and fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia or myelodysplastic syndromes has been approved by the FDA.
Read More
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen
